The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Paraneoplastic Neurological Syndromes — Advanced Management

Heterogeneous group of immune-mediated neurological disorders triggered by an underlying neoplasm, requiring rapid antibody profiling, tumor screening, and combined immunotherapy to halt neurological progression while treating cancer.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Paraneoplastic Neurological Syndromes — Advanced Management?

Paraneoplastic neurological syndromes (PNS) are remote, non-metastatic effects of cancer on the nervous system mediated by autoimmunity directed against shared neuronal and tumor antigens, classified as definite, probable, or possible based on the 2021 PNS-Care Score criteria.

Onconeural antibodies are categorized as high-risk (formerly classical: anti-Hu, Yo, Ri, CV2/CRMP5, Ma2, amphiphysin, SOX1) — strongly associated with cancer, intracellular targets — versus intermediate-risk (anti-NMDAR, GABA-B-R, AMPAR, LGI1, CASPR2) targeting cell-surface or synaptic proteins, often immunotherapy-responsive.

Diagnostic workup includes serum and CSF antibody panels, body PET-CT or CT for occult tumor, brain and spine MRI, and neurophysiology; treatment combines tumor-directed therapy with immunotherapy escalation.

Symptoms

Limbic encephalitis: subacute memory loss, confusion, behavioral change, temporal lobe seizures
Cerebellar degeneration: rapidly progressive ataxia, dysarthria, vertical nystagmus, oscillopsia
Sensory neuronopathy: asymmetric sensory loss, sensory ataxia, painful paresthesias, autonomic dysfunction
Lambert-Eaton myasthenic syndrome: proximal weakness, areflexia, dysautonomia, post-exercise facilitation
Opsoclonus-myoclonus-ataxia: chaotic eye movements, myoclonic jerks, ataxia (children with neuroblastoma, adults with breast or lung cancer)
Stiff-person syndrome, anti-NMDAR encephalitis, brainstem encephalitis, myelopathy, dermatomyositis with cancer association

Risk Factors

Small-cell lung cancer (most common cause overall), thymoma, ovarian or breast cancer, testicular germ cell tumors
Hodgkin and non-Hodgkin lymphoma — anti-mGluR5, anti-Tr/DNER
Smoking, asbestos exposure, age over 50, and family history of cancer
Existing autoimmune disease may predispose to PNS development
Some HLA haplotypes associated with specific antibody syndromes
Earlier identification correlates with better neurological recovery; delayed diagnosis worsens outcome

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Subacute neurological deterioration with memory loss, ataxia, or sensory loss — urgent neurology referral
  • New seizures with behavioral or psychiatric features in adult — workup for encephalitis including paraneoplastic causes
  • Known cancer with new neurological symptoms — combined oncology and neurology evaluation
  • Failure of standard treatment for atypical neurological disease — antibody panel and tumor screen
  • Suspected paraneoplastic syndrome without identified cancer — body PET-CT and serial imaging at 6-month intervals for up to 2 years

Treatment Methods

01
Identify and treat underlying tumor — surgical resection, chemotherapy, radiation as appropriate; tumor control often essential for neurological improvement
02
First-line immunotherapy: high-dose IV methylprednisolone (1 g/day for 5 days) and intravenous immunoglobulin (2 g/kg over 2–5 days) or plasma exchange
03
Second-line immunotherapy: rituximab, cyclophosphamide for refractory or progressing cases, particularly for cell-surface antibody syndromes (anti-NMDAR, LGI1, CASPR2, GABA-B-R)
04
Long-term immunosuppression: mycophenolate, azathioprine, or maintenance rituximab to prevent relapse, especially in cell-surface antibody disease
05
Symptomatic management: anticonvulsants for seizures, plasmapheresis for crises, physical and occupational therapy for ataxia and weakness, pain management for sensory neuropathy, psychiatric support; long-term follow-up for tumor recurrence and immunotherapy side effects

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Stroke

Nöroloji

What is stroke, what are the FAST signs, and why is emergency intervention critical?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.